Kali, Inc.

8300 Douglas Ave Suite 800
Dallas, TX
United States 75225

Recent News

  • KALY Announces Cannabis Biopharmaceutical Technology Business Consolidation

    Dallas, Texas--(Newsfile Corp. - January 14, 2020) - Kali-Extracts, Inc. (OTC Pink: KALY) (Kali, Inc. dba/Kali-Extracts, Inc.) ("KALY") today announced plans to consolidate its business structure and focus on its Cannabis Biopharmaceutical Technology. KALY has a U.S. Patented Cannabis Extraction Process and is developing treatments for various medical conditions. ...

    2020-01-14 10:22 AM ET
  • KALY to Release $50 Million 2020 Biopharmaceutical Technology Strategy Next Week

    Dallas, Texas--(Newsfile Corp. - January 8, 2020) - Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (OTC Pink: KALY) ("KALY") today announced that management will release its 2020 Cannabis Biopharmaceutical Technology Strategy next week on Tuesday, January 14, 2020. KALY has a U.S. Patented Cannabis Extraction Process and is developing ...

    2020-01-08 9:08 AM ET
  • KALY - Kali-Extracts Announces Reaching $1 Million In Sales

    Dallas, Texas--(Newsfile Corp. - December 23, 2019) - Kali-Extracts, Inc. (OTC Pink: KALY) (Kali, Inc. dba/Kali-Extracts, Inc.) ("KALY") today announced that the Company has reached $1 million in sales. Subject to an accounting review of its overall 2019 financials, management anticipates reporting over $1 million in revenue for 2019. ...

    2019-12-23 12:42 PM ET
  • KALY Announces Anchor Investor in Cannabis Biopharmaceutical Technology at $50 Million Valuation

    Dallas, Texas--(Newsfile Corp. - December 17, 2019) - Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (OTC Pink: KALY) ("KALY") today announced an anchor investor in its biopharmaceutical technology. KALY recently announced restructuring its cannabis biopharmaceutical business as part of a strategy to facilitate a strategic investment at a $50 million ...

    2019-12-17 9:47 AM ET
  • KALY - Kali-Extracts Expects 2020 Revenue Growth Acceleration from CBD Infused Consumer Products

    Dallas, Texas--(Newsfile Corp. - December 11, 2019) - Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (OTC Pink: KALY) ("KALY") today announced expected revenue growth acceleration in 2020 from the sales of CBD infused consumer products. The company currently generates revenue from the sale of CBD infused candies and beverages. ...

    2019-12-11 9:34 AM ET
  • KALY - Kali-Extracts Announces Cannabis Biopharmaceutical Business Restructuring

    Dallas, Texas--(Newsfile Corp. - December 10, 2019) - Kali-Extracts, Inc. (OTC Pink: KALY) (Kali, Inc. dba/Kali-Extracts, Inc.) ("KALY") today announced the company is restructuring its cannabis biopharmaceutical business. KALY has a U.S. Patented Cannabis Extraction Process and is developing treatments for various medical conditions (see below). ...

    2019-12-10 8:50 AM ET
  • KALY - Kali-Extracts Proceeds With Capital Infusion Plan At $50 Million Valuation

    Dallas, Texas--(Newsfile Corp. - December 6, 2019) - Kali-Extracts, Inc. (OTC Pink: KALY) (Kali, Inc. dba/Kali-Extracts, Inc.) ("KALY") today announced it will proceed with a capital infusion plan to accelerate the growth of its cannabis biopharmaceutical technology. KALY has recently announced receiving two inquiries into the acquisition of the ...

    2019-12-06 9:25 AM ET